Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Juan José Valerdi"'
Autor:
Maite Martínez Aguillo, M. Gutiérrez, Francisco Javier Domínguez del Valle, Enrique Martínez López, Juan José Albistur Tomé, Elena Pruja Arteaga, Juan José Valerdi Álvarez
Publikováno v:
Clinical and Translational Oncology. 6:219-223
Introduction Since the decade of the 80's, the etoposide plus cisplatinum regimen has been the standard treatment in patients with localised small-cell lung cancer (SCLC). Randomised trials have demonstrated the benefit of chemotherapy in combination
Autor:
Ruth Vera García, M. Gutiérrez, Juan José Valerdi Álvarez, Fernando Arias de la Vega, Juan José Albistur Tomé, Javier Arellano Aburto, Juan Ignacio Arraras Urdaniz
Publikováno v:
Revista de Oncología. 5:465-470
Introduction The effectiveness of neoadjuvant chemotherapy (Mayo clinic schedule) and continuous oral chemotherapy (tegafur 400 mg and folinic acid 15 mg every 12 hours) administered during preoperative radiotherapy (4,500 cGy over 5 weeks) were stud
Autor:
Ruth Vera García, Begoña Bermejo Fraile, Juan Ignacio Arraras Urdaniz, Juan José Valerdi Álvarez, Francisco Molina Rosillo, Juan José Albistur Tomé, M. Gutiérrez
Publikováno v:
Revista de Oncología. 4:250-254
The main purpose of this prospective non randomized trial was to analyse whether induction chemotherapy and hyperfractionated radiotherapy combined with cisplatin can improve the long-term survival of patients with locally advanced non small cell lun
Autor:
Fernando Arias, E. Pruja, M. Tejedor, Enrique Martínez, M. Marcos, Juan Ignacio Arraras, Juan José Valerdi
Publikováno v:
Psycho-Oncology. 11:249-256
The EORTC Quality of Life Study Group has developed a questionnaire for evaluating Quality of Life in international clinical trials: QLQ-C30. The purpose of the present work is to validate the third version of this questionnaire (3.0) for use in Spai
Autor:
Miguel Ángel Domínguez Domínguez, M. Gutiérrez, Juan José Valerdi Álvarez, Ruth Vera García, Elena Pruja Arteaga, Juan Ignacio Arraras Urdaniz, Marta Marcos Oset, José Juan Illarramendi Mañas
Publikováno v:
Revista de Oncología. 3:100-106
The aim of the present study was to evaluate the quality of life in a sample of breast cancer patients during treatment.
Autor:
Ricardo Hitt, Juan José Valerdi álvarez, Rafael Trujillo Vílchez, Emilio Alba Conejo, ángel Jiménez Lacave, José Andrés Moreno Nogueira, Joaquín Fra Rodríguez
Publikováno v:
Revista de Oncología. 2:253-258
El estudio se llevo a cabo para conocer en una muestra de 309 mujeres con cancer de mama tratadas con quimioterapia adyuvante estandar el porcentaje de pacientes que recibe el 100% de la intensidad de dosis teorica prevista, profundizando en las caus
Autor:
Miguel Angel Dominguez, Fernando Arias, Juan José Valerdi, Martín Tejedor, Luis Mendez, Jose Juan Illarramendi, Elena Pruja
Publikováno v:
Cytokines, Cellular & Molecular Therapy. 6:35-39
An open-label, non-randomized study evaluated the feasibility and efficacy of filgrastim (recombinant methionyl human granulocyte colony-stimulating factor, r-metHuG-CSF) to prevent mucositis induced by accelerated hyperfractionated radiotherapy (1.6
Autor:
Francisco Molina, Miguel Angel Dominguez, Mayte Dueñas, Rosa Meiriño, Fernando Arias, Juan José Valerdi, E. Villafranca, Jose Juan Illarramendi, Enrique Martínez, Martín Tejedor
Publikováno v:
Cancer. 80:115-120
BACKGROUND Chemoradiotherapy is becoming an alternative to radical cystectomy among patients with bladder carcinoma invading muscle. In 1988, the authors began a protocol with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC regimen) and
Autor:
Maite Dueñas, Santiago Miquéliz, Fernando Arias, Martín Tejedor, Juan José Valerdi, Fernando Elcarte, Enrique Martínez, JoséJ. Illarramendi, E. Villafranca, Miguel Angel Dominguez, Severina Domínguez
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 33:675-682
Purpose : The feasibility and activity of an intensive chemoradiotherapeutic scheme for patients with locally advanced squamous cells head and neck cancers were tested in a single institution Phase II pilot study. Methods and materials : Between Janu
Publikováno v:
Psycho-Oncology. 4:191-196
This study investigated ‘truth telling’ to the patient in Navarre, Spain. Knowledge of diagnosis amongst a group of 89 advanced cancer patients was compared with the hypothetical desire for information of a convenience sample of 78 non-patients.